Tony Smith

Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston.

Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

ProteinSimple engages in the proprietary systems and consumables for protein analysis. Its products include simple plex, ice, simple western, micro-flow imaging, and single-cell western. The company was founded by Linda Cahill, Nancy Allbritton, Christopher Sims, Scott Lockard, and Jim Schlater in December 2000 and is headquartered in San Jose, CA.

Evonetix Ltd. is a biotechnology company. The firm offers pharmaceuticals and drug discovery, industrial biotech and renewables, materials science, agriculture, digital data storage, and food and beverages. The company was founded by Hermann Maria Hauser and Joseph Brennan in 2015 and is headquartered in Little Chesterford, the United Kingdom.

Part of Agilisys Holdings Ltd., Vocalis Ltd. develops and markets speech recognition applications for telephone systems and computers. The company is based in Cambridge, UK. The British company was founded by Hermann Maria Hauser.

Part of Liberty Global Ltd., NetChannel UK is a telecommunications company. NetChannel UK is based in London, UK. The British company was founded by Hermann Maria Hauser, Jean-Paul Stephen Rohan.

PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom.

Cavendish Kinetics, Inc. provides radio frequency tuning solutions for mobile devices in the wireless industry. It is a fabless supplier of tunable components for RF circuits used in cellular handsets, laptops, netbooks, tablets, and other consumer wireless devices. The firm offers tunable RF circuits, based on third-generation RF MEMS technology and its semiconductor processes, let users pack more performance into the same space. The company was founded by Charles Gordon Smith and Hermann M. Hauser in 1994 and is headquartered in San Jose, CA.

Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom.

Part of Amadeus Partners Ltd., Amadeus General Partner Ltd. provides investment services. The company is based in Edinburgh, UK. Founded in 1997.

PolyAI Ltd. platform for conversational AI. The company was founded by Tsung-Hsien Wen, Nikola Mrk?ic and Pei-Hao Su and is headquartered in London, the United Kingdom.

The Japanese company has a wealth of experience in micro-biome research and have obtained high-quality microbial genome data from various samples. The company is based in Tokyo, Japan. The company strategically combines their own single-cell analysis technology, bit-map®, to realize the next-generation microbiome analysis that approaches the essence of microbial functions. The company also uses the microbial genomic information owned by bitBiome to provide new knowledge for research and development promoted by joint partners and customers. The company was founded by Yoshihito Daimon, Masahito Hosokawa. Kimihiko Sato has been the CEO of the company since 2020.

Bit Bio Ltd. engages in research and experimental development on natural sciences and engineering. Its products are human-induced skeletal myocytes and glutamatergic neurons. The company was founded by Mark Kotter in 2016 and is headquartered in Cambridge, the United Kingdom.

APEX Ventures GmbH (APEX Ventures) is a venture capital firm founded in 2016 by Christoph Kanneberger and Andreas Riegler. The firm is headquartered in Vienna, Austria.

Onsight Ventures Management GmbH (Onsight Ventures) is a venture capital firm founded in 2021. The firm is headquartered in Innsbruck, Austria.

Rho Capital Partners, Inc. (Rho Capital Partners) is a venture capital firm founded in 1981 by Joshua Ruch. The firm is headquartered in New York.

Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA.

Cambridge Network Ltd. operates as a membership organization. It bring people together to meet each other and share ideas, encouraging collaboration and partnership for shared success. The company was founded by Alec Broers, Hermann Hauser, David Cleevely, Nigel Brown, Fred Hallsworth, and Anthony Ross in 1998 and is headquartered in Cambridge, the United Kingdom.

Part of ION Investment Group Ltd., Olivetti UK Ltd. is a company that specializes in the sale and maintenance of information processing systems, office products, and software. The company is based in Milton Keynes, UK.

Anjarium Biosciences AG is a Swiss company that focuses on creating a new class of non-viral gene therapies to tackle genetic diseases throughout a patient's lifetime. The company is based in Schlieren, Switzerland. The company's versatile platform leverages breakthrough science and expertise at the interface of genetic medicine, synthetic biology, and nanoparticle engineering to generate a pipeline of advanced gene therapies with unique competitive advantages over current viral-vector based gene therapies. Anjarium's investors include leading international and strategic investors such as Abingworth, Gimv, Omega Funds, Pfizer Ventures, and Surveyor Capital. The company was founded by Joël de Beer, and Stephen Yoo has been the CEO of the company since 2022.